although
sasa
quelpaertensi
nakai
dwarf
bamboo
known
exert
varieti
benefici
effect
health
antivir
effect
remain
elucid
porcin
reproduct
respiratori
syndrom
viru
prrsv
one
devast
viral
pathogen
swine
substanti
econom
impact
global
pork
industri
therefor
present
studi
conduct
determin
whether
sasa
quelpaertensi
nakai
extract
sqe
inhibit
prrsv
infect
cultur
porcin
alveolar
macrophag
pam
result
demonstr
sqe
treatment
suppress
replic
prrsv
dosedepend
manner
antivir
activ
sqe
prrsv
replic
found
primarili
exert
earli
time
postinfect
treatment
sqe
result
mark
reduct
viral
genom
subgenom
rna
synthesi
viral
protein
express
progeni
viru
product
notabl
proinflammatori
cytokin
product
pam
cell
infect
prrsv
shown
modul
presenc
sqe
taken
togeth
data
indic
sqe
potenti
therapeut
agent
prrsv
porcin
reproduct
respiratori
syndrom
viru
prrsv
pathogen
macrophagetrop
arteriviru
pig
etiolog
agent
acut
respiratori
ill
young
piglet
reproduct
failur
pregnant
sow
prrsv
small
envelop
singlestrand
positivesens
rna
viru
belong
famili
arterivirida
order
nidoviral
prrsv
genom
contain
two
larg
open
read
frame
orf
compris
twothird
viral
genom
encod
nonstructur
protein
nsp
remain
orf
locat
termin
region
code
structur
protein
initi
translat
yield
lab
replicas
polyprotein
respect
proteolyt
process
least
function
nsp
includ
viral
rnadepend
rna
polymeras
rdrp
rdrpcontain
replic
complex
mediat
genom
rna
replic
subgenom
sg
mrna
transcript
eventu
gener
nest
set
cotermin
sg
mrna
individu
translat
produc
structur
protein
prrsv
preferenti
replic
porcin
alveolar
macrophag
pam
establish
persist
infect
lymphoid
tissu
infect
pig
last
sever
month
result
prrsv
infect
suppress
normal
macrophag
function
immun
respons
may
render
pig
suscept
secondari
bacteri
viral
infect
lead
moresever
diseas
caus
either
agent
alon
furthermor
highli
pathogen
prrsv
infect
character
high
fever
high
mortal
pig
age
recent
emerg
china
asian
countri
sever
affect
local
pig
husbandri
although
kill
modifi
live
vaccin
prrsv
develop
control
diseas
use
global
market
commerci
vaccin
problem
relat
efficaci
safeti
despit
avail
vaccin
prrsv
still
continu
plagu
porkproduc
nation
caus
enorm
financi
loss
swine
industri
worldwid
thu
lack
effect
vaccin
increas
need
new
compound
prrsv
infect
sasa
quelpaertensi
nakai
known
jejujoritda
type
bamboo
grass
wide
distribut
mt
halla
jeju
island
south
korea
leaf
extract
possess
number
healthpromot
activ
includ
antiulcerogen
antiobes
antiinflammatori
anticanc
properti
date
still
report
effect
sasa
quelpaertensi
nakai
extract
sqe
viral
infect
human
veterinari
subject
present
studi
therefor
tri
investig
antivir
activ
sqe
mechan
action
target
cell
upon
prrsv
infect
treatment
target
cell
sqe
significantli
impair
prrsv
replic
experi
reveal
sqe
suppress
postentri
step
replic
cycl
prrsv
includ
viral
genom
sg
rna
synthesi
viral
protein
express
viru
product
presenc
sqe
notabl
alter
express
cytokin
gene
prrsvinfect
pam
cell
suggest
sqe
activ
involv
modul
inflammatori
respons
viral
infect
collect
result
suggest
sqe
may
excel
therapeut
option
prrsv
infect
cell
virus
reagent
antibodi
pamknu
cell
immort
pam
cell
line
cultur
rpmi
medium
invitrogen
carlsbad
ca
supplement
fetal
bovin
serum
fb
invitrogen
antibioticantimycot
solut
invitrogen
mm
hepe
invitrogen
mm
sodium
pyruv
invitrogen
nonessenti
amino
acid
invitrogen
presenc
lgml
invitrogen
cell
maintain
humidifi
co
incub
prrsv
strain
propag
pamknu
cell
describ
previous
sqe
kind
gift
yong
chool
boo
kyungpook
nation
univers
daegu
south
korea
prepar
dissolv
distil
water
dw
describ
elsewher
yield
sqe
dri
quelpaertensi
leav
kg
approxim
pcoumar
acid
purchas
sigma
st
loui
mo
dissolv
dimethyl
sulfoxid
dmso
monoclon
antibodi
mab
prrsv
n
protein
purchas
rural
technolog
brook
sd
antibactin
antibodi
horseradish
peroxidas
hrp
conjug
secondari
antibodi
purchas
santa
cruz
biotechnolog
santa
cruz
ca
cytotox
effect
reagent
pamknu
analyz
bromid
mtt
assay
sigma
detect
cell
viabil
briefli
pamknu
cell
grown
densiti
cellswel
tissu
cultur
plate
sqe
pcoumar
acid
treatment
h
incub
mtt
solut
mgml
ad
well
sampl
incub
addit
h
supernat
remov
well
dmso
ad
dissolv
formazan
crystal
produc
mtt
absorb
solut
measur
nm
use
enzymelink
immunosorb
assay
plate
reader
mtt
assay
perform
triplic
pamknu
cell
grown
microscop
coverslip
place
tissu
cultur
plate
pretreat
sqe
pcoumar
acid
h
mock
infect
infect
prrsv
multipl
infect
moi
presenc
compound
virusinfect
cell
allow
grow
presenc
sqe
pcoumar
acid
hpi
fix
paraformaldehyd
min
room
temperatur
rt
permeabil
triton
pb
rt
min
cell
block
bovin
serum
albumin
bsa
pb
min
rt
incub
nspecif
mab
h
wash
five
time
pb
cell
incub
h
rt
goat
antimous
secondari
antibodi
conjug
alexa
fluor
molecular
probe
carlsbad
ca
follow
counterstain
dapi
sigma
coverslip
mount
glass
microscop
slide
mount
buffer
glycerol
sodium
azid
pb
cell
stain
visual
use
fluoresc
leica
dm
il
led
microscop
leica
wetzlar
germani
pamknu
cell
grown
tissu
cultur
plate
day
mock
infect
infect
prrsv
moi
indic
time
cell
harvest
lysi
buffer
mm
bglycerophosph
mm
qnitro
phenyl
phosphat
mm
mop
mm
mgcl
mm
nacl
mm
egta
ph
mm
sodium
orthovanad
lgml
lgml
aprotinin
lgml
leupeptin
mm
pmsf
sonic
ice
five
time
homogen
lyse
min
ice
clarifi
centrifug
eppendorf
centrifug
hamburg
germani
min
protein
concentr
cell
lysat
determin
bca
protein
assay
pierc
rockford
il
cell
lysat
mix
nupag
sampl
buffer
invitrogen
boil
min
protein
separ
nupag
gradient
bistri
gel
invitrogen
reduc
condit
electrotransf
onto
immobilonp
membran
millipor
billerica
membran
subsequ
block
powder
skim
milk
bd
bioscienc
belford
tb
mm
trishcl
ph
mm
nacl
tbst
h
react
overnight
primari
antibodi
prrsv
n
bactin
blot
incub
secondari
horseradish
peroxidas
hrp
label
antibodi
dilut
h
protein
visual
addit
enhanc
chemiluminesc
ecl
reagent
amersham
bioscienc
piscataway
nj
accord
manufactur
instruct
quantifi
viral
protein
product
band
densiti
prrsv
n
protein
quantit
analyz
use
comput
densitomet
wright
cell
imag
facil
wcif
version
imagej
softwar
packag
http
wwwuhnresearchca
facilitieswcifimagej
base
densiti
valu
rel
bactin
gene
pamknu
cell
infect
prrsv
moi
describ
hpi
sqe
ad
reach
indic
final
concentr
remaind
time
cours
experi
virusinfect
sqetreat
cell
maintain
infect
termin
hpi
fix
monolay
paraformaldehyd
min
rt
fix
cell
subject
ifa
assess
presenc
prrsv
infect
describ
intern
assay
perform
describ
previous
briefli
pamknu
cell
grown
cultur
plate
infect
prrsv
moi
h
presenc
sqe
unbound
virus
wash
pb
cell
incub
presenc
sqe
h
follow
treatment
proteinas
k
mgml
min
remov
bound
nonintern
viru
particl
prrsvinfect
cell
serial
dilut
rpmi
ad
fresh
pamknu
cell
monolay
tissu
cultur
plate
h
postincub
intern
virus
titrat
ifa
describ
tissu
cultur
infecti
dose
tcid
calcul
quantit
realtim
rtpcr
pamknu
cell
incub
sqe
h
prior
infect
inocul
prrsv
moi
h
viru
inoculum
subsequ
remov
infect
cell
maintain
fresh
medium
contain
sqe
h
total
rna
extract
lysat
infect
cell
hpi
use
trizol
reagent
invitrogen
treat
dnase
takara
otsu
japan
accord
manufactur
protocol
concentr
extract
rna
measur
use
nanovu
spectrophotomet
ge
healthcar
piscataway
nj
quantit
realtim
rtpcr
conduct
use
thermal
cycler
dice
real
time
system
takara
genespecif
primer
set
describ
previous
primer
use
studi
describ
elsewher
primer
sequenc
avail
request
rna
level
viral
cytokin
gene
normal
mrna
porcin
bactin
gene
rel
quantiti
rq
mrna
accumul
determin
use
ddct
method
detect
alter
genom
rna
sg
mrna
level
presenc
sqe
prrsv
infect
result
obtain
use
sqetreat
sampl
compar
obtain
vehicletr
sampl
assess
effect
sqe
transcript
activ
proand
antiinflammatori
cytokin
virusinfect
cell
rel
fold
chang
cytokin
gene
calcul
compar
virusinfect
mockinfect
pam
cell
vehicletr
sqetreat
virusinfect
cell
pamknu
cell
treat
sqe
mgml
h
prior
infect
follow
prrsv
inocul
moi
h
infect
cell
maintain
fresh
medium
contain
sqe
vehicl
h
total
rna
extract
lysat
infect
cell
hpi
use
trizol
reagent
treat
dnase
describ
northern
blot
conduct
use
northernmax
kit
ambion
austin
tx
accord
manufactur
instruct
sampl
total
rna
lg
load
onto
agaros
gel
separ
electrophoresi
use
denatur
buffer
system
separ
total
rna
transfer
brightstarplu
nylon
membran
ambion
h
crosslink
exposur
uv
light
min
prehybrid
perform
min
follow
detect
use
genotypespecif
probe
utr
aatttcggccgcatggttttcgccaattaaatctt
porcin
rrna
g
blot
hybrid
biotinlabel
oligonucleotid
probe
ultrahyb
reagent
overnight
wash
twice
lowstring
block
buffer
wash
buffer
target
viral
rna
detect
use
brightstar
biodetect
kit
ambion
accord
manufactur
protocol
membran
incub
alkalinephosphataseconjug
streptavidin
follow
reaction
chemiluminesc
substrat
cdpstar
ambion
overlaid
film
expos
dark
cassett
box
dark
room
quantit
perform
densitometri
correspond
band
describ
pamknu
cell
infect
prrsv
along
sqe
treatment
describ
cultur
supernat
collect
differ
time
point
hpi
store
titer
prrsv
measur
limit
dilut
pamknu
cell
ifa
describ
quantifi
tcid
per
ml
student
ttest
use
statist
analys
pvalu
less
consid
statist
signific
investig
antivir
activ
sqe
prrsv
chosen
one
import
viral
pathogen
econom
impact
global
pork
industri
base
mtt
assay
highest
concentr
sqe
noncytotox
mgml
pamknu
cell
pamknu
cell
pretreat
sqe
concentr
mgml
dw
vehicl
control
h
prior
infect
sqe
present
entir
period
infect
viru
product
initi
measur
monitor
cytopath
effect
cpe
infect
confirm
immunofluoresc
hpi
use
nproteinspecif
mab
fig
vehicletr
control
cell
visibl
cpe
appear
hpi
becam
promin
hpi
nspecif
stain
clearli
evid
mani
cell
cluster
indic
infect
spread
viru
neighbor
cell
contrast
sqe
obviou
inhibitori
effect
viru
propag
shown
fig
b
sqe
significantli
decreas
virusinduc
cpe
viral
gene
express
concentr
mgml
n
protein
stain
reveal
number
cell
express
viral
antigen
decreas
sqe
treatment
result
maximum
inhibit
concentr
mg
ml
fig
b
furthermor
effect
dose
inhibit
prrsv
infect
ed
determin
mgml
taken
togeth
result
demonstr
sqe
effici
suppress
replic
prrsv
determin
point
sqe
act
prrsv
infect
pamknu
cell
treat
independ
sqe
variou
time
point
postinfect
hpi
level
prrsv
replic
measur
indirectli
use
ifa
determin
number
cell
express
n
protein
fig
treatment
cell
mgml
sqe
hpi
result
decreas
prrsvposit
cell
compar
untreat
control
addit
sqe
hpi
led
decreas
number
prrsvinfect
cell
contrast
signific
impair
prrsv
propag
observ
sqe
ad
hpi
data
indic
inhibitori
effect
sqe
exert
mainli
initi
period
infect
suggest
action
occur
earli
time
point
prrsv
infect
assess
effect
sqe
prrsv
replic
viru
yield
determin
treatment
sqe
viral
supernat
collect
hpi
viral
titer
measur
shown
fig
treatment
sqe
inhibit
releas
viral
progeni
dosedepend
manner
peak
viral
titer
determin
tcid
ml
vehicletr
control
prrsv
addit
mgml
sqe
decreas
titer
prrsv
tcid
ml
log
reduct
compar
control
growth
kinet
studi
demonstr
overal
process
prrsv
replic
significantli
delay
cell
treat
sqe
fig
consequ
find
reveal
sqe
inhibit
optim
releas
progeni
viru
natur
host
cell
evalu
step
replic
cycl
prrsv
target
sqe
start
focus
earliest
step
viru
entri
address
issu
intern
assay
perform
describ
previous
pamknu
cell
inocul
prrsv
h
allow
viru
attach
maintain
either
permit
viru
intern
presenc
sqe
sampl
treat
proteinas
k
remov
remain
virus
cell
surfac
serial
dilut
infect
cell
subsequ
subject
infecti
center
assay
uninfect
pamknu
cell
monolay
viru
titer
measur
day
later
ifa
shown
fig
titer
prrsv
virtual
cell
treat
sqe
without
sqe
determin
indic
differ
cell
contrast
minim
viral
product
tcid
ml
observ
prrsvinfect
cell
maintain
like
due
ineffici
remov
bound
viru
result
indic
sqe
inhibitori
effect
viru
entri
process
follow
uncoat
process
like
positivesens
rna
virus
genom
prrsv
releas
cytoplasm
immedi
serv
templat
viral
translat
cellular
capdepend
mechan
earli
viral
translat
produc
replicas
polyprotein
posttransl
cleav
nsp
viral
cellular
proteinas
subsequ
replicas
protein
mediat
de
novo
synthesi
viral
rna
includ
genom
rna
replic
sg
mrna
transcript
structur
protein
prrsv
translat
later
respect
sg
mrna
transcript
thu
investig
inhibitori
effect
sqe
postentri
step
prrsv
life
cycl
first
investig
whether
viral
protein
translat
affect
sqe
accomplish
pamknu
cell
treat
sqe
h
prior
infect
drug
allow
remain
infect
subsequ
incub
express
level
prrsv
n
protein
presenc
absenc
sqe
evalu
hpi
western
blot
analysi
product
prrsv
n
protein
drastic
diminish
sqe
treatment
fig
densitometr
analysi
western
blot
reveal
intracellular
express
viral
protein
reduc
sqe
treatment
maximum
inhibit
concentr
mgml
fig
mark
reduct
probabl
result
nonspecif
decreas
translat
sinc
ponceau
stain
indirectli
indic
overal
express
level
cellular
protein
remain
similar
follow
treatment
data
shown
taken
togeth
result
demonstr
inhibitori
effect
sqe
specif
viral
protein
express
prrsv
replic
positivestrand
rna
virus
viral
nonstructur
protein
requir
viral
rna
replic
transcript
thu
conceiv
impair
viral
protein
express
caus
suppress
viral
rna
synthesi
sinc
prrsv
infect
produc
two
rna
entiti
genom
subgenom
investig
whether
sqe
specif
affect
genom
replic
sg
mrna
transcript
answer
question
rel
level
genom
rna
sg
mrna
measur
quantit
realtim
strandspecif
rtpcr
presenc
absenc
sqe
upon
prrsv
infect
shown
fig
sqe
treatment
result
maxim
reduct
synthesi
prrsv
genom
rna
sg
mrna
respect
concentr
mg
ml
compar
untreat
infect
cell
decreas
viral
rna
level
addit
sqe
due
nonspecif
inhibit
transcript
mrna
level
intern
bactin
control
remain
unchang
sampl
fig
impair
prrsv
transcript
presenc
sqe
confirm
northern
blot
analysi
fig
absenc
sqe
prrsv
rna
synthesi
distinctli
observ
lane
reduct
rnasynthes
activ
occur
presenc
mg
sqe
per
ml
lane
viral
rna
synthesi
almost
complet
abolish
presenc
mg
sqe
per
ml
lane
altogeth
result
indic
sqe
specif
suppress
synthesi
prrsv
genom
rna
sg
mrna
sinc
sqe
report
antiinflammatori
properti
examin
whether
sqe
affect
transcript
activ
immunerespons
gene
upon
prrsv
infect
determin
whether
contribut
b
fig
reduct
viral
progeni
product
sqe
treatment
pamknu
cell
pretreat
sqe
h
mock
infect
infect
viru
sqe
present
medium
throughout
infect
hpi
viruscontain
supernat
collect
viru
titer
determin
b
growth
kinet
prrsv
pamknu
cell
treat
sqe
use
experiment
condit
panel
indic
time
point
postinfect
cultur
supernat
harvest
viru
titer
measur
c
virusintern
assay
conduct
infect
pamknu
cell
prrsv
moi
h
wash
cold
pb
infect
cell
maintain
presenc
absenc
sqe
either
addit
hour
bound
nonintern
viru
particl
remov
treatment
proteinas
k
infect
cell
serial
dilut
plate
onto
pamknu
cell
tissu
cultur
plate
day
postincub
intern
virus
titrat
use
ifa
detect
tissu
cultur
infecti
dose
tcid
calcul
result
express
mean
valu
triplic
well
error
bar
repres
standard
deviat
p
fig
inhibit
viral
protein
translat
sqe
treatment
sqetreat
pamknu
cell
mockinfect
infect
prrsv
h
cultiv
presenc
absenc
sqe
hpi
cell
lysat
collect
resolv
sdspage
transfer
nitrocellulos
membran
immunoblot
use
prrsvspecif
antibodi
recogn
prrsv
n
protein
blot
also
react
mous
mab
bactin
verifi
equal
protein
load
amount
viral
protein
estim
densitometri
term
band
densiti
rel
bactin
sqetreat
sampl
result
compar
vehiclecontrol
result
valu
repres
mean
three
independ
experi
error
bar
denot
standard
deviat
p
inhibit
prrsv
sasa
quelpaertensi
nakai
extract
antivir
activ
found
numer
immunerel
gene
regul
prrsv
infect
significantli
alter
treat
cell
sqe
compar
result
obtain
vehicletr
virusinfect
cell
fig
among
upregul
tnfa
mrna
level
prrsv
infect
dramat
reduc
presenc
sqe
howev
chemokin
gene
modul
prrsv
includ
rant
synergist
elev
sqe
treatment
interestingli
unchang
slightli
increas
mrna
level
interferon
regulatori
factor
irf
tolllik
receptor
tlr
antivir
gene
includ
b
fig
inhibit
viral
rna
transcript
sqe
pamknu
cell
pretreat
sqe
mock
infect
infect
prrsv
h
incub
presenc
sqe
total
cellular
rna
extract
hpi
black
bar
hpi
white
bar
viral
genom
rna
sg
mrna
amplifi
quantit
realtim
rtpcr
viral
positivesens
genom
rna
sg
mrna
b
normal
mrna
porcin
bactin
mrna
c
rel
quantiti
rq
mrna
accumul
evalu
sqetreat
sampl
result
compar
untreat
result
valu
repres
mean
three
independ
experi
error
bar
denot
standard
deviat
p
p
fig
suppress
viral
rna
synthesi
sqe
treatment
pamknu
cell
treat
sqe
follow
prrsv
inocul
indic
lane
total
rna
extract
lysat
infect
cell
hpi
subject
northern
blot
analysi
use
genotypespecif
biotinlabel
oligonucleotid
probe
utr
porcin
rrna
use
control
correct
variat
load
viral
rna
quantif
amount
viral
sg
mrna
quantifi
densitometri
normal
prrsvinfect
untreat
control
cell
posit
genom
rna
sg
mrna
indic
next
gel
significantli
increas
prrsvinfect
pam
cell
treat
sqe
compar
vehicletr
infect
cell
result
indic
sqe
modul
cytokin
gene
inflammatori
respons
prrsv
infect
prrsv
devast
viral
pathogen
pig
popul
also
use
anim
viru
model
studi
nidovirus
import
human
veterinari
medicin
despit
tremend
effort
control
diseas
caus
viru
prrsv
infect
continu
plagu
pigproduc
countri
tremend
econom
impact
global
swine
industri
partial
due
absenc
effici
vaccin
capabl
confer
full
protect
heterolog
viral
infect
well
antivir
agent
treat
prrsv
although
sqe
wide
known
possess
sever
healthpromot
properti
antivir
activ
mode
action
dna
rna
virus
current
unknown
present
studi
demonstr
sqe
exert
adequ
antivir
effect
prrsv
vitro
determin
ed
viral
replic
antivir
activ
approxim
mgml
treatment
cell
sqe
result
signific
inhibit
postentri
step
replic
prrsv
demonstr
reduc
progeni
product
diminish
viral
protein
express
reduc
synthesi
genom
rna
sg
mrna
furthermor
growth
kinet
experi
indic
approxim
reduct
titer
prrsv
presenc
sqe
h
infect
titer
continu
remain
similar
level
h
infect
taken
togeth
data
indic
sqe
potent
elicit
antivir
activ
prrsv
natur
target
cell
compound
medicin
plant
natur
sourc
interest
potenti
inhibit
varieti
viral
infecti
diseas
cancer
bamboo
grass
use
tradit
medicin
throughout
asia
modern
studi
report
benefici
health
effect
sasa
quelpaertensi
nakai
among
well
known
jejujoritda
south
korea
sqe
leaf
extract
number
biolog
properti
includ
anticanc
antiinflammatori
effect
sinc
prrsv
infect
modul
inflammatori
cytokin
express
pam
cell
antivir
activ
sqe
may
result
predominantli
antiinflammatori
effect
elucid
potenti
mechan
respons
antivir
effect
sqe
prrsv
first
test
whether
sqe
affect
induct
cytokin
gene
prrsv
immort
pam
cell
present
studi
provid
evid
variou
cytokin
induc
prrsvinfect
cell
transcript
modul
presenc
sqe
result
indic
treatment
sqe
robustli
reduc
infectioninduc
express
proinflammatori
cytokin
includ
tnfa
contrast
sqe
result
synerg
elev
gene
express
level
chemokin
notabl
induct
irf
tlr
gene
involv
antivir
immun
respons
specif
enhanc
sqetreat
virusinfect
cell
prrsv
known
possess
abil
escap
host
defens
mechan
interf
innat
immun
respons
favor
surviv
spread
natur
host
thu
sqe
appear
disrupt
one
pivot
viral
mechan
immun
evas
modifi
express
immunerel
gene
facilit
viru
infect
result
suppress
prrsv
replic
howev
unabl
identifi
chemic
constitu
sqe
respons
regul
immunerespons
gene
express
lead
antivir
activ
upon
prrsv
infect
although
pcoumar
acid
known
major
compon
sqe
mgg
divers
pharmacolog
properti
includ
antimicrobi
anticanc
antiulc
activ
chemic
incap
significantli
impair
replic
prrsv
even
highest
noncytotox
concentr
lm
fig
conceiv
minor
constitu
tricin
content
sqe
mgg
may
possess
biolog
characterist
give
sqe
antivir
activ
inde
recent
studi
demonstr
inhibitori
effect
synthes
tricin
deriv
viral
infect
addit
prrsv
experi
extend
nidovirus
confirm
antivir
activ
sqe
porcin
epidem
diarrhea
viru
pedv
one
pathogen
coronavirus
pig
like
prrsv
belong
order
nidoviral
whose
member
similar
genom
organ
replic
strategi
thu
attempt
assess
whether
sqe
also
affect
pedv
infect
found
signific
inhibitori
effect
pedv
infect
vitro
fig
observ
might
explain
tropism
viru
sinc
prrsv
porcin
macrophagetrop
arteriviru
caus
acut
respiratori
ill
wherea
pedv
pathogen
enterocytetrop
coronaviru
swine
caus
acut
enter
wateri
diarrhea
although
sqe
fail
block
pedv
infect
still
potenti
antivir
agent
coronavirus
human
livestock
modul
immunerespons
cytokin
gene
product
natur
host
relat
replic
conclus
find
describ
demonstr
sqe
subcytotox
dose
effect
prevent
replic
prrsv
natur
host
cell
addit
sqe
treatment
significantli
alter
prrsvinduc
fig
regul
immunerel
gene
sqe
prrsv
infect
presenc
vehicl
sqe
mgml
pamknu
cell
mock
infect
infect
prrsv
moi
total
rna
extract
lysat
infect
cell
hpi
left
bar
set
hpi
right
bar
set
mrna
level
cytokin
gene
assess
quantit
realtim
rtpcr
normal
porcin
bactin
rel
fold
differ
mockinfect
virusinfect
cell
yaxi
calcul
gene
compar
untreat
sqetreat
virusinfect
cell
data
repres
mean
valu
three
independ
experi
carri
duplic
error
bar
repres
standard
deviat
p
p
cytokin
product
pam
cell
therefor
propos
one
mode
action
sqe
elicit
antivir
effect
prrsv
regul
express
immunerel
gene
associ
abil
prrsv
escap
host
innat
immun
respons
although
vivo
studi
need
evalu
efficaci
safeti
sqe
result
present
indic
good
candid
antivir
agent
prrsv
